Blanka Jamnicky

Title: Blanka Jamnicky: Innovator in Pharmaceutical Chemistry

Introduction

Blanka Jamnicky is a notable inventor based in Zagreb, YU. She has made significant contributions to the field of pharmaceutical chemistry, particularly through her innovative patents. Her work focuses on the synthesis of biologically active compounds, which have important applications in medicine.

Latest Patents

Blanka holds a patent for N-sulfonyl-tetrahydro-[1,3]-dioxepino[5,6-b]azirines. This invention involves the synthesis of novel tetrahydro-[1,3]-dioxepino[5,6-b]azirines starting from cis-2-butene-1,4-diol. The process includes the use of 4,7-dihydro-1,3-dioxepin and trans-6-acylamino-5-chloro-1,3-dioxepans. The resulting compounds are valuable intermediates in the synthesis of other biologically active substances, showcasing her innovative approach to drug development.

Career Highlights

Throughout her career, Blanka has worked with prominent companies in the pharmaceutical industry, including Pliva Handels GmbH and Pliva, Inc. Her experience in these organizations has allowed her to collaborate with other talented professionals and contribute to significant advancements in her field.

Collaborations

Blanka has collaborated with notable coworkers such as Miljenko Dumic and Darko Filic. These partnerships have enriched her research and development efforts, leading to innovative solutions in pharmaceutical chemistry.

Conclusion

Blanka Jamnicky's contributions to the field of pharmaceutical chemistry through her patents and collaborations highlight her role as an influential inventor. Her work continues to impact the development of biologically active substances, showcasing the importance of innovation in medicine.